Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...

No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says. More. Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022.

Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...

Pfizer And Drug Pricing: Should You Invest Now? May 15, 2025 — 01:55 am EDT. ... At its current price of $23, Pfizer stock trades at just 8 times trailing earnings of $2.91 per share.

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers, had a meeting with the Trump administration to talk about reducing US ...

Pfizer Inc. (PFE) CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump administration to discuss lowering U.S. drug prices. Bourla said ...

Trump's so-called “most favored nation” approach to Medicare drug pricing has been controversial since he ... by Medicare and Medicaid because it can set regulations. ... Pfizer, which notched ...

Pfizer received FDA approval May 6 for Vyndaqel, which treats a rare and fatal heart disease. The drug will launch with a list price of $225,000 per year in the U.S., according to Reuters.

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.